Listen "Why Cell and Gene Therapies Cost So Much – And What Can Be Done"
Episode Synopsis
Last week's episode introduced the promises and challenges brought forth by Cell and Gene Therapies. Today's show dives deeper into this topic with BU Questrom Professor Rena Conti, an expert on the financing and regulation of the biopharmaceutical market.
She and host Curt Nickisch discuss why these treatments are so expensive, challenges for insurance companies, and potential solutions to ensure fair access.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
She and host Curt Nickisch discuss why these treatments are so expensive, challenges for insurance companies, and potential solutions to ensure fair access.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
More episodes of the podcast Is Business Broken?
The Economic Anxiety of a Global Trade Shift
26/06/2025
How to Combat Common Ownership
10/04/2025
Why is Healthcare Not Better and Cheaper?
20/03/2025
Are CEOS Paid Just For Luck?
06/03/2025
Why are Executives Paid So Much?
20/02/2025